Federal Register / Vol. 66, No. 29 / Monday, February 12, 2001 / Notices 9869

Date: March 5–6, 2001.

Time: 12:15 p.m. to 1 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: National Cancer Institute, Building

31, C Wing, 6th Floor, Conference Rooms 6,

9000 Rockville Pike, Bethesda, MD 20892.

Contact Person: Abby B. Sandler, PhD,

Scientific Review Administrator, Office of

the Director, Intramural Review Office,

National Cancer Institute, National Institutes

of Health, 6116 Executive Boulevard, Room

7019, Bethesda, MD 20852, 301/496–7628.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: February 2, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3456 Filed 2–9–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel Training

Grants.

Date: February 21, 2001.

Time: 6 p.m. to 10 p.m.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Holiday Inn, 2101

Wisconsin Avenue, NW., Washington, DC

20007.

Contact Person: David E. Maslow, PhD,

Scientific Review Administrator, Grants

Review Branch, Division of Extramural

Activities, National Cancer Institute, National

Institutes of Health, 6116 Executive

Boulevard—Room 8054, Bethesda, MD

20892–7405, 301/496–2330.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: February 2, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3457 Filed 2–9–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel Small

Grants Program for Cancer Epidemiology and

Cancer Prevention Research.

Date: March 6–7, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hilton Gaithersburg, 620 Perry

Parkway, Gaithersburg, MD 20877.

Contact Person: Mary Jane Slesinski, PhD,

Scientific Review Administrator, Special

Review and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, National Institutes of Health, 6116

Executive Boulevard, Room 8045, Bethesda,

MD 20892, 301/594–1566.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: February 2, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–3458 Filed 2–9–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the meeting of the

Nation Cancer Advisory Board.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

A portion of the meeting will be

closed to the public in accordance with

the provisions set forth in sections

552b(c)(4), and 552b(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

wouldconstitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Advisory Board.

Dates: February 12–14, 2001.

Name of Committee: National Cancer

Advisory Board Ad Hoc Subcommittee on

Communications.

Open: February 12, 7 p.m. to 8:30 p.m.

Agenda: To discuss activities related to the

Ad Hoc Subcommittee on Communications.

Place: Bethesda Hyatt Regency, One

Bethesda Metro Center, Bethesda, MD 20814.

(301) 657–1234.

Contact Person: Susan Sieber, PhD.,

Executive Secretary to the Ad Hoc

Subcommittee on Communications, Director,

Office of Communications, National Cancer

Institute, National Institutes of Health, 31

Center Drive, Building 31, Room 11A48,

Bethesda, MD 20892, (301) 496–5946.

Name of Committee: National Cancer

Advisory Board.

Open: February 13, 9 a.m. to 12:05 p.m.